AAIPharma bulks up; Teva CEO Yanai to retire;

> AAIPharma is buying equipment and adding a filling line at one North Carolina facility, adding a second work shift at another, and building a 40,000-square-foot lab and technology center at its Wilmington headquarters site. Story | Story

> Teva Pharmaceutical president ($TEVA) and CEO Shlomo Yanai plans to retire in May 2012; Jeremy Levin, formerly with Bristol-Myers Squibb, is expected to succeed him. Teva release

> Athena Drug Delivery Solutions will develop, manufacture and commercialize AtorFen (fenofibrate-atorvastin fixed dose combination), an investigational cholesterol drug from Veloxis Pharmaceuticals, which will get 70% of revenues. News

> Micro Labs has ordered GEA Pharma Systems' Flexstream process technology for spray granulation and pellet coating. Item

> Alarmed over the domestic pharma companies being acquired by multinational Big Pharmas, Indian officials have done away with automatic approvals for foreign direct investment. Report

> A new three-layer heat-sealed plastic film from BASF will protect the active ingredient Kollidon against contact with oxygen, allowing a lower peroxide level of the material. News

> Actavis has named Agility Spain to transport 300 pallets of drugs from a Malta production site to 15 European countries for generics launches. Item

> For sale: A well-established pharmaceutical manufacturing and marketing company available for immediate majority equity acquisition or outright sale in India. Listing